ConductScience.org, home

Paper36958362

Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study.

Man KKC and 22 others. Lancet Psychiatry, 2023. Cited by 66 papers, by iCite.

Cite this record

ConductScience Library. Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study. Papers, record 36958362. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36958362

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study.
PubMed
Journal
Lancet Psychiatry
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
66
iCite
Relative citation ratio, by iCite
12.7
iCite
Revised in PubMed
2026-05-18
PubMed

Authors23

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Man KKCKenneth K C
2Häge AAlexander
3Banaschewski TTobias
4Inglis SKSarah K
5Buitelaar JJan
6Carucci SSara
7Danckaerts MMarina
8Dittmann RWRalf W
9Falissard BBruno
10Garas PPeter
11Hollis CChris
12Konrad KKerstin
13Kovshoff HHanna
14Liddle EElizabeth
15McCarthy SSuzanne
16Neubert AAntje
17Nagy PPeter
18Rosenthal EEric
19Sonuga-Barke EJSEdmund J S
20Zuddas AAlessandro

Source PubMed

See all 23 authorsDownload CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MethylphenidateMajor topic
Attention Deficit Disorder with HyperactivityMajor topic
Central Nervous System StimulantsMajor topic
Child
Adolescent
Humans
Male
Female
Psychotropic Drugs
Germany
Treatment Outcome

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in36958361Long-term safety of methylphenidate in children with ADHD.https://conductscience.org/library/papers/36958361

Source PubMed

Download CSV of comments and corrections

Cited by41

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.

PMIDTitleJournalYearIn PapersSource
42656627
Disproportionality analysis of methylphenidate-associated adverse events in pediatric patients using the FDA Adverse Event Reporting System: overall signals and stratification by gender and dosage form.
Front Psychiatry2026https://conductscience.org/library/papers/42656627PubMed
42627426Clinical practices in ADHD management across Europe: findings from the ESCAP research academy survey.Eur Child Adolesc Psychiatry2026https://conductscience.org/library/papers/42627426PubMed
42564791Self-reported ADHD symptoms among pharmacy students: prevalence of positive ADHD symptom screening, academic correlates, and implications for educational support.Front Psychiatry2026https://conductscience.org/library/papers/42564791PubMed
42469203Effects of methylphenidate on the human vascular endothelium.Transl Psychiatry2026https://conductscience.org/library/papers/42469203PubMed
42415397A Randomised Open-Label Comparison of Dexamphetamine and Methylphenidate in Children With Attention Deficit Hyperactivity Disorder (ADHD): Symptom Response, Adherence and Weight Impact Over 12 Months.J Paediatr Child Health2026https://conductscience.org/library/papers/42415397PubMed
42199906Effect of methylphenidate on physical growth indicators in children and adolescents with attention-deficit/hyperactivity disorder: a systematic review and meta-analysis.Front Psychiatry2026https://conductscience.org/library/papers/42199906PubMed
42168718The Evolving Pharmacological Landscape for Paediatric and Adult ADHD.CNS Drugs2026https://conductscience.org/library/papers/42168718PubMed
42083867Psychiatric safety of methylphenidate in adults with major depressive disorder: a 1-year retrospective cohort study of 6,422 patients.Psychol Med2026https://conductscience.org/library/papers/42083867PubMed
41769062Severe self-limiting acute bilateral hearing loss following a low dose of methylphenidate for ADHD treatment: A case report.PCN Rep2026https://conductscience.org/library/papers/41769062PubMed
41627718Tolerance and Tachyphylaxis to Medications for Attention-Deficit/Hyperactivity Disorder (ADHD): A Systematic Review of Empirical Studies.CNS Drugs2026https://conductscience.org/library/papers/41627718PubMed
41490109ADHD and Methylphenidate Use in Prepubertal Children and BMI and Height at Adulthood.JAMA Netw Open2026https://conductscience.org/library/papers/41490109PubMed
41185813The Neuropsychology of Chronic Neurological Disorders: A Review of Cognitive and Emotional Impairments.Cureus2025https://conductscience.org/library/papers/41185813PubMed
41182374Use of methylphenidate and the risk of cardiovascular diseases in children and adolescents with a family history of heart diseases and congenital heart diseases: A self-controlled case series study.Eur Child Adolesc Psychiatry2026https://conductscience.org/library/papers/41182374PubMed
41112607Effects of attention-deficit hyperactivity disorder on growth in children and adolescents: A systematic review and meta-analysis.World J Psychiatry2025https://conductscience.org/library/papers/41112607PubMed
41099844Sex differences in the response to treatment of attention deficit hyperactivity disorder.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/41099844PubMed
40694311Current insights into the safety and adverse effects of methylphenidate in children, adolescents, and adults - narrative review.Pharmacol Rep2025https://conductscience.org/library/papers/40694311PubMed
40670510Clinical outcomes of a 12-week, first treatment with methylphenidate in an Italian representative sample of children and adolescents with ADHD.Sci Rep2025https://conductscience.org/library/papers/40670510PubMed
40629932Children and Young Adults Who Used Medication for Attention Deficit Hyperactivity Disorder Faced Increased Cardiac Risks.Acta Paediatr2025https://conductscience.org/library/papers/40629932PubMed
40332610Duration of ADHD medication treatment among Finnish children and adolescents ‒ a nationwide register study.Eur Child Adolesc Psychiatry2025https://conductscience.org/library/papers/40332610PubMed
40176288Prevalence of attention deficit hyperactivity disorder in homeless children and adolescents: A systematic review and meta-analysis.Dialogues Clin Neurosci2025https://conductscience.org/library/papers/40176288PubMed

See all 41 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36958362

GET https://conductscience.org/api/papers/v1/36958362/authors?page=2